Drug firm Orchid Chemicals & Pharmaceuticals has said that it has received final US regulatory approval for its drug Sumatriptan Succinate tablets used for the treatment of migraine attacks. The company has received final US Food and Drug Administration (USFDA) approval, Orchid Chemicals said in a filing to the Bombay Stock Exchange (BSE). The approval of Sumatriptan Succinate tablets are in the strengths of 25 mg, 50 mg and 100 mg.
Every time an offender stealthily leaves India to take refuge in another country, the Government of India starts all over again with its strategy of bringing him back to the nation to make him stan More
Helplinelaw can set up your session with quality and experienced lawyers to discuss and resolve your legal matters. You can avail consultation in form of sending questions, phone call or webchat discussion More